© 2001 by the American Diabetes Association, Inc. Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic SubunitRelated Protein Gene Promoter by In Situ FootprintingCorrelation With Fusion Gene Expression in the Islet-Derived ßTC-3 and Hamster Insulinoma Tumor Cell Lines
1 Department of Molecular Physiology and Biophysics, Vanderbilt University Medical School, Nashville, Tennessee Glucose-6-phosphatase (G6Pase) is a multicomponent system located in the endoplasmic reticulum comprising a catalytic subunit and transporters for glucose-6-phosphate, inorganic phosphate, and glucose. We have recently cloned a novel gene that encodes an islet-specific G6Pase catalytic subunitrelated protein (IGRP) (Ebert et al., Diabetes 48:543551, 1999). To begin to investigate the molecular basis for the islet-specific expression of the IGRP gene, a series of truncated IGRPchloramphenicol acetyltransferase (CAT) fusion genes were transiently transfected into the islet-derived mouse ßTC-3 and hamster insulinoma tumor cell lines. In both cell lines, basal fusion gene expression decreased upon progressive deletion of the IGRP promoter sequence between -306 and -66, indicating that multiple promoter regions are required for maximal IGRP-CAT expression. The ligation-mediated polymerase chain reaction footprinting technique was then used to compare trans-acting factor binding to the IGRP promoter in situ in ßTC-3 cells, which express the endogenous IGRP gene, and adrenocortical Y1 cells, which do not. Multiple trans-acting factor binding sites were selectively identified in ßTC-3 cells that correlate with regions of the IGRP promoter identified as being required for basal IGRP-CAT fusion gene expression. The data suggest that hepatocyte nuclear factor 3 may be important for basal IGRP gene expression, as it is for glucagon, GLUT2, and Pdx-1 gene expression. In addition, binding sites for several trans-acting factors not previously associated with islet gene expression, as well as binding sites for potentially novel proteins, were identified.
Abbreviations: CAT, chloramphenicol acetyltransferase; DMEM, Dulbeccos modified Eagles medium; DTT, dithiothreitol; GSD, glycogen storage disease; G6P, glucose-6-phosphate; G6Pase, glucose-6-phosphatase; HNF, hepatocyte nuclear factor; IGRP, islet-specific G6Pase catalytic subunitrelated protein; LMPCR, ligation-mediated polymerase chain reaction; MUT, mutant; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; TBE, 89 mmol/l Tris + 89 mmol/l boric acid + 2 mmol/1 EDTA; WT, wild type
This article has been cited by other articles:
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||